NCT04847726View on ClinicalTrials.gov

Contrast-enhanced Ultrasound With Perfluorobutane and Sulfur Hexafluoride for Hepatocellular Carcinoma

NACompletedINTERVENTIONAL
Enrollment

110

Participants

Timeline

Start Date

June 9, 2020

Primary Completion Date

July 30, 2021

Study Completion Date

October 30, 2021

Conditions
Hepatocellular Carcinoma
Interventions
DIAGNOSTIC_TEST

contrast enhanced ultrasound

contrast enhanced ultrasound with perfluorobutane and sulfur hexafluoride

DIAGNOSTIC_TEST

Dynamic CT

Participants underwent dynamic CT for hepatic lesion

DIAGNOSTIC_TEST

Liver MRI

Participants underwent liver MRI for hepatic lesion

Trial Locations (1)

03038

Seoul National University Hospital, Seoul

All Listed Sponsors
lead

Seoul National University Hospital

OTHER

NCT04847726 - Contrast-enhanced Ultrasound With Perfluorobutane and Sulfur Hexafluoride for Hepatocellular Carcinoma | Biotech Hunter | Biotech Hunter